Cite
Metabolomics and cytokine profiling of mesenchymal stromal cells identify markers predictive of T-cell suppression.
MLA
Maughon, Ty S., et al. “Metabolomics and Cytokine Profiling of Mesenchymal Stromal Cells Identify Markers Predictive of T-Cell Suppression.” Cytotherapy (Elsevier Inc.), vol. 24, no. 2, Feb. 2022, pp. 137–48. EBSCOhost, https://doi.org/10.1016/j.jcyt.2021.08.002.
APA
Maughon, T. S., Shen, X., Huang, D., Michael, A. O. A., Shockey, W. A., Andrews, S. H., McRae III, J. M., Platt, M. O., Fernández, F. M., Edison, A. S., Stice, S. L., & Marklein, R. A. (2022). Metabolomics and cytokine profiling of mesenchymal stromal cells identify markers predictive of T-cell suppression. Cytotherapy (Elsevier Inc.), 24(2), 137–148. https://doi.org/10.1016/j.jcyt.2021.08.002
Chicago
Maughon, Ty S., Xunan Shen, Danning Huang, Adeola O. Adebayo Michael, W. Andrew Shockey, Seth H. Andrews, Jon M. McRae III, et al. 2022. “Metabolomics and Cytokine Profiling of Mesenchymal Stromal Cells Identify Markers Predictive of T-Cell Suppression.” Cytotherapy (Elsevier Inc.) 24 (2): 137–48. doi:10.1016/j.jcyt.2021.08.002.